Neurology · 2003 · 81 citations · 10 references
PharmacyPharmacologyClinical PharmacologyDrug Utilization ReviewPharmacovigilanceAdverse Drug Event PreventionExposure-response AnalysisPharmacoepidemiologyStrokeCase-control Study DesignDose Adjustment AssessmentHemorrhagic Risk Assessment
This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of < or =32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.
10
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
Walter N. Kernan, Catherine M. Viscoli, Lawrence Brass et al. · New England Journal of Medicine · 2000 · 773 citations · Full text
Exercise and Cardiovascular Health
Jonathan Myers · Circulation · 2003 · 457 citations · Full text
Education, Kinesiology, Physiology +12
Use of Nonprescription Weight Loss Products
Heidi M. Blanck, Laura Kettel Khan, Mary K. Serdula · JAMA · 2001 · 153 citations